Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Dianthus Therapeutics, Inc. (DNTH)

82.38 -0.32 (-0.39%)
At close: October 30 at 4:00:01 PM EDT
82.38 0.00 (0.00%)
After hours: October 30 at 4:00:16 PM EDT
Trade DNTH on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
1,904
2,036
6,235
2,826
6,417
Operating Expense
219,748
179,969
108,099
51,000
36,122
Operating Income
-217,844
-177,933
-101,864
-48,174
-29,705
Net Non Operating Interest Income Expense
26,732
16,119
17,365
4,764
1,145
Other Income Expense
-1,134
-523
-470
-145
84
Pretax Income
-192,246
-162,337
-84,969
-43,555
-28,476
Net Income Common Stockholders
-192,246
-162,337
-84,969
-43,555
-28,476
Diluted NI Available to Com Stockholders
-192,246
-162,337
-84,969
-43,555
-28,476
Basic EPS
-4.24
-4.20
-2.55
-8.45
-1.92
Diluted EPS
-4.24
-4.20
-2.55
-8.45
-1.92
Basic Average Shares
46,740.80
38,617.58
33,313.85
5,153.71
14,817.70
Diluted Average Shares
46,740.80
38,617.58
33,313.85
5,153.71
14,817.70
Total Operating Income as Reported
-217,844
-177,933
-101,864
-48,174
-29,705
Total Expenses
219,748
179,969
108,099
51,000
36,122
Net Income from Continuing & Discontinued Operation
-192,246
-162,337
-84,969
-43,555
-28,476
Normalized Income
-192,500
-162,788
-85,053
-43,470
-28,612
Interest Income
26,732
16,119
17,365
4,764
1,145
Net Interest Income
26,732
16,119
17,365
4,764
1,145
EBIT
-217,844
-177,933
-101,864
-48,174
-29,705
EBITDA
-217,465
-177,505
-101,452
-47,819
-29,558
Reconciled Depreciation
379
428
412
355
147
Net Income from Continuing Operation Net Minority Interest
-192,246
-162,337
-84,969
-43,555
-28,476
Total Unusual Items Excluding Goodwill
254
451
84
-85
136
Total Unusual Items
254
451
84
-85
136
Normalized EBITDA
-217,719
-177,956
-101,536
-47,734
-29,694
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 6/21/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: